An Open Labeled, Prospective, Single-center, Clinical Study to Evaluate the Safety of Jeevanprash (JP) in Healthy Individuals in Summer. - NI

Alkem Laboratories Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects meeting all of the following criteria will be included to the trial-
•Males and Females, age group between 20-40 years
•Ready to provide written informed consent
•No significant diseases or clinically abnormal laboratory blood profiles during screening.
•ECG without significant abnormalities
•Be able to communicate effectively with study personnel
•No history of allergic conditions and is not on regular medical treatment

•Subjects meeting any of the following criteria will be excluded from the trial-
•Any significant disease condition which would affect subjectâ??s participation or compliance to study protocol
•History of allergic conditions
•History of autoimmune disorders
•History of HIV I & II, Hepatitis.
•History or presence of dyspepsia, gastric ulcer or duodenal ulcer.
•History of any psychiatric disorders.
•Intake of any medication within 14 days before the start of the study.
•Recent history of alcoholism ( <2 years) or consumption of alcohol within 48 hours of receiving study medication.
•Smokers who cannot refrain from smoking during the study period.
•Presence of clinically significant abnormal laboratory results during screening.
•Pregnancy or not using appropriate means of contraception.
•History of drug addiction.

发起方